PLIANT THERAPEUTICS, INC. — All Filings
405 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POS EX
POSASR
PRE 14A
PRER14A
S-1
S-1/A
S-3ASR
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| PRE 14A | PRE 14A | 0001746473-25-000070 | Apr 10, 2025 | Dec 31, 2024 |
| 8-A12B | 8-A12B | 0001193125-25-053509 | Mar 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-053541 | Mar 13, 2025 | Mar 12, 2025 |
| SCHEDULE 13D | — | 0001214659-25-004133 | Mar 10, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000999 | Mar 7, 2025 | — |
| 8-K | 8-K | 0001746473-25-000051 | Mar 3, 2025 | — |
| 10-K | 10-K | 0001746473-25-000054 | Mar 3, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001746473-25-000056 | Mar 3, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-014382 | Feb 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-025663 | Feb 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-023130 | Feb 10, 2025 | Feb 7, 2025 |
| 4 | FORM 4 | 0001746473-25-000011 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | FORM 4 | 0001746473-25-000009 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | FORM 4 | 0001746473-25-000013 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | FORM 4 | 0001746473-25-000015 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | FORM 4 | 0001746473-25-000017 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | FORM 4 | 0001746473-25-000019 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | FORM 4 | 0001746473-25-000001 | Jan 22, 2025 | Jan 17, 2025 |
| 4 | FORM 4 | 0001746473-25-000002 | Jan 22, 2025 | Jan 17, 2025 |
| 4 | FORM 4 | 0001746473-25-000003 | Jan 22, 2025 | Jan 17, 2025 |
| 4 | FORM 4 | 0001746473-25-000004 | Jan 22, 2025 | Jan 17, 2025 |
| 4 | FORM 4 | 0001746473-25-000005 | Jan 22, 2025 | Jan 17, 2025 |
| 4 | FORM 4 | 0001746473-25-000006 | Jan 22, 2025 | Jan 17, 2025 |
| 144 | — | 0001950047-25-000390 | Jan 22, 2025 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001839882-24-039284 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001140361-24-046979 | Nov 14, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-119430 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000080255-24-001456 | Nov 14, 2024 | — |
| SC 13G/A | LAURION CAPITAL MANAGEMENT LP | 0001085146-24-005528 | Nov 12, 2024 | — |
| 8-K | 8-K | 0001746473-24-000169 | Nov 7, 2024 | — |
| 10-Q | 10-Q | 0001746473-24-000171 | Nov 7, 2024 | Sep 30, 2024 |
| SC 13G | SC 13G | 0001104659-24-106351 | Oct 4, 2024 | — |
| 8-K | 8-K | 0001746473-24-000153 | Sep 27, 2024 | Sep 24, 2024 |
| 10-Q | 10-Q | 0001746473-24-000145 | Aug 7, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001746473-24-000143 | Aug 7, 2024 | — |
| 8-K | 8-K | 0001193125-24-178937 | Jul 15, 2024 | — |
| 4 | FORM 4 | 0001746473-24-000123 | Jul 12, 2024 | Jul 10, 2024 |
| 4 | FORM 4 | 0001746473-24-000121 | Jul 12, 2024 | Jul 10, 2024 |
| 4 | FORM 4 | 0001746473-24-000125 | Jul 12, 2024 | Jul 10, 2024 |
| 4 | FORM 4 | 0001746473-24-000129 | Jul 12, 2024 | Jul 10, 2024 |
| 4 | FORM 4 | 0001746473-24-000127 | Jul 12, 2024 | Jul 10, 2024 |
| 4 | FORM 4 | 0001746473-24-000111 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | FORM 4 | 0001746473-24-000119 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | FORM 4 | 0001746473-24-000115 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | FORM 4 | 0001746473-24-000113 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | FORM 4 | 0001746473-24-000117 | Jul 11, 2024 | Jul 9, 2024 |
| 4 | FORM 4 | 0001746473-24-000108 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | FORM 4 | 0001746473-24-000106 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | FORM 4 | 0001746473-24-000107 | Jun 17, 2024 | Jun 13, 2024 |
| 4 | FORM 4 | 0001746473-24-000105 | Jun 17, 2024 | Jun 13, 2024 |